Directors: MARIA REIG and JORDI BRUIX

14:30-15:00 CET Welcome
Antoni Castells. Medical Director of Hospital Clínic of Barcelona.
Jordi Bruix. Head of BCLC at IDIBAPS and CIBERehd.
Maria Reig. Head of the Liver Cancer Unit at Hospital Clínic of Barcelona.

15:00-15:45 CET The evolving landscape in liver cancer and the future challenges
Chair: Carmen Ayuso (Spain)

15:00-15:20 CET: The 2021 BCLC staging and treatment strategy
Presentation: Maria Reig (Spain)

15:20-15:45 CET: Panelists: Gonzalo Sapisochín (Canada), Bruno Sangro (Spain) ,
Jean-Charles Nault (France), Lorenza Rimassa (Italy) and Amit
Singal (USA)

15:45-15:55 CET: Break

15:55-16:40 CET The exciting future of Resection and Liver Transplantation
Chair: Joana Ferrer (Spain)

15:55-16:10 CET: Liver surgery: what will drive the surpass of the current limitations
Presentation: Vincenzo Mazzaferro (Italy)

16:10-16:40 CET: Panelists: Christian Toso (Switzerland), Julie Heimbach (USA),
Massimo Iavarone (Italy) and Norihiro Kokudo (Japan)

16:40-17:40 CET Artificial intelligence: which will be its application in the next 5 years?
Chair: Jordi Rimola (Spain)

16:40-17:10 CET: The development of AI in Oncology:
Presentation: Radiological point of view: Karim Lekadir (Spain)
Biology-Pathology point of view: Tom Luedde (Germany)

17:10-17:40 CET: Panelists: Julien Calderaro (France), Julius Chapiro (USA), Alba
Díaz (Spain)

17:40-18:20 CET Scientific evidence beyond clinical trials for evidence-based management of liver cancer
Chair: Jordi Bruix (Spain)

17:40-18:00 CET: Can phase 3 randomized controlled trials lose primacy?
Presentation: Armin Koch (Germany)

18:00-18:20 CET: Panelists: Peter Galle (Germany), Nicole Rich (USA), Fabio Piscaglia
(Italy) and Ferran Torres (Spain)

18:20-18:25 CET: Break

18:25-19:00 CET Will the microbiota become a tool for prognosis prediction or for prediction of treatment benefit?
Chair: Maria Reig (Spain) and Tom Karlsen (Norway)

18:25-18:40 CET: The incorporation of microbiota in precision medicine
Presentation: Johannes E.R. Hov (Oslo)

18:40-19:00 CET: Panelists: Marco Sanduzzi (Spain), Jasmohan Bajaj (USA), Climent Casals (Spain).

19:00-19:45 CET Loco-regional treatments: What will be their place in the era of immunotherapy?
Chair: Jordi Bruix (Spain)

19:00-19:15 CET: Which are the factors that can change the clinical decision-making?
Presentation: Bruno Sangro (Spain)

19:15-19:45 CET: Panelists: Katie Kelley (USA), Pierre Nahon (France), Jens Ricke
(Germany), Laura Dawson (Canada) , Marta Burrel (Spain) , Riad Salem (USA)

19:45-20:25 CET Cholangiocarcinoma: linking profile to therapy. Has it been validated?
Chair: Alejandro Forner (Spain)

19:45-20:00 CET: Unfolding the development and stratified treatment approach of
cholangiocarcinoma

Presentation: Sumera Ilyas (USA)

20:00-20:25 CET: Panelists: Juan Valle (UK ), Valérie Paradis (France) and Domenico
Alvaro (Italy)

20:25-20:30 CET: Meeting Closure : Maria Reig and Jordi Bruix

NOVEMBER 23rd

10:30-12:00 CET
DIAGNOSIS AND STAGING (ENGLISH)
Alba Díaz, Alejandro Forner, Jordi Rimola

12:30-14:00 CET
SURGICAL – LOCOREGIONAL TREATMENT (ENGLISH)
Anna Darnell, Joana Ferrer, Jordi Bruix, Marta Burrel

18:00-19:30 CET
TRATAMIENTO SISTÉMICO (SPANISH)
Maria Reig, Gemma Iserte

NOVEMBER 24th

12:30-14:00 CET
SYSTEMIC TREATMENT (ENGLISH)
Jordi Rimola, Maria Reig, Gemma Iserte, Jordi Bruix

16:00-17:30 CET
DIAGNÓSTICO Y ESTADIAJE (SPANISH)
Alejandro Forner, Jordi Rimola, Alba Díaz

18:00-19:30 CET
TRATAMIENTO QUIRÚRGICO -LOCOREGIONAL (SPANISH)
Angeles Garcia Criado, Joana Ferrer, Jordi Bruix, Marta Burrel

English